NCT03253718

Brief Summary

Background: The Human Motor Control Section does tests for people with movement disorders. In order to be sure when a test is normal or abnormal, normal values must be determined in a large group of healthy volunteers (HVs). Therefore, the researchers want to study the techniques in HVs. They will use the results as the standard of comparison in future clinical studies. Objective: To get enough normal results in movement tests to use in clinical studies. Eligibility: Healthy adults ages 18-68 Design: Participants will be screened with medical history and physical and neurological exams. Participants will have 1 to 3 visits. They may have: Small sticky electrodes attached to the skin on the hands/arms and neck. These will measure muscle activity. Tiny shocks given to a finger. Participants will be asked if they felt 1 or 2 shocks. This will be done to each hand over about 30 minutes total. A questionnaire about anxiety. Acoustic startle reflex test. Small electrodes will be stuck to the eye, hand, and leg. Sensors will be stuck to the palms. Small metal electrodes on the chest and inner arm will measure heart rate. Participants will wear headphones. Once everything is in place, participants will hear a low sound for about 10 minutes. They will hear a short louder sound every 45 60 seconds.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 18, 2017

Completed
3.8 years until next milestone

Study Start

First participant enrolled

May 25, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2021

Completed
Last Updated

May 27, 2021

Status Verified

May 1, 2021

Enrollment Period

Same day

First QC Date

August 17, 2017

Last Update Submit

May 26, 2021

Conditions

Keywords

Healthy Volunteers

Outcome Measures

Primary Outcomes (2)

  • STDT values in both hands

    Sub-study 1: Somatosensory Temporary Discrimination Threshold (STDT): STDT values in both hands.

    throughout protocol

  • The amount, latency and duration of muscle activity, heart rate, and skin conductance.

    Sub-study 2: Acoustic Startle Reflex (ASR): The amount, latency and duration of muscle activity, heart rate, and skin conductance.

    throughout protocol

Study Arms (1)

Healthy Volunteers

Healthy Volunteers between 18 and 68 years of age

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HV s will be recruited through NIH Patient Recruitment and Public Liaison Office and from our database of individuals who have participated in prior studies and are interested in being contacted for additional studies.

You may qualify if:

  • Between 18 and 68 years of age
  • Ability to give informed consent
  • Able to understand the procedures and requirements of the study

You may not qualify if:

  • Diagnosis of a neurological disorder
  • Illegal drug use within the past six months. The intent is to exclude those with drug use that may affect study results
  • Self-reported consumption of \>7 alcoholic drinks a week for women and \>14 alcoholic drinks a week for men
  • Unwillingness to abstain from caffeine or alcohol on the day of the study
  • Abnormal findings on neurological exam of clinical significance
  • History of or current brain tumor, stroke, head trauma with loss of consciousness \> few seconds, epilepsy or seizures
  • Open scalp wounds or scalp infections
  • For ASR, unwillingness to abstain from the use of cigarettes on the day of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

Study Officials

  • Mark Hallett, M.D.

    National Institute of Neurological Disorders and Stroke (NINDS)

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2017

First Posted

August 18, 2017

Study Start

May 25, 2021

Primary Completion

May 25, 2021

Study Completion

May 25, 2021

Last Updated

May 27, 2021

Record last verified: 2021-05

Locations